Dámaso Molero
Vorstandsvorsitzender bei 3P Biopharmaceuticals SL
Profil
Dámaso Molero is currently the Chief Executive Officer at 3P Biopharmaceuticals SL.
Previously, he held positions as Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche & Genentech, Inc. He obtained his undergraduate degree and MBA from the University of Navarra.
Aktive Positionen von Dámaso Molero
| Unternehmen | Position | Beginn |
|---|---|---|
3P Biopharmaceuticals SL
 3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Vorstandsvorsitzender | 01.04.2007 |
Ehemalige bekannte Positionen von Dámaso Molero
| Unternehmen | Position | Ende |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
| Syntex, Inc. | Corporate Officer/Principal | - |
| Glaxo, Inc. | Corporate Officer/Principal | - |
Ausbildung von Dámaso Molero
| University of Navarra | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SHIONOGI & CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology 3 P Biopharmaceuticals SL operates as contract development and manufacturing organization. It specializes in the process development and GMP production of biopharmaceuticals and cell therapy products. The firm has experience in projects covering all stages in different expression systems including mammalian, bacterial, and yeast. The company was founded on January 20, 2006 and is headquartered in Noáin, Spain. | Health Technology |
| Glaxo, Inc. | |
| Syntex, Inc. | Miscellaneous |
